Sanjiv S. Agarwala, MD: Let’s talk about melanoma brain metastases, a very big problem.
Video Reports
Unmet Needs and Future Treatments of Metastatic Melanoma
The big problem in melanoma continues to be the fact that resistance develops so often to these treatments.
The Use of Dual Targeted Therapy in Metastatic Melanoma
The data for the COMBI studies are very interesting. COMBI-d was a study where dabrafenib and trametinib was compared with dabrafenib alone in patients with melanoma in the first line.
Developments in the Management of Stage III Melanoma
Hussein A. Tawbi, MD, PhD: Patients with stage III melanoma are defined as patients who have nodal involvement from their disease.